Dr Diana L Hill, PHARMD in Rison, AR - Pharmacist

Dr Diana L Hill, PHARMD is a Pharmacist based in Rison, Arkansas. Dr Diana L Hill is licensed to practice in Arkansas (license number PD11947) and her current practice location is 300 Pine St, Rison, Arkansas. She can be reached at her office (for appointments etc.) via phone at (870) 325-6262.

NPI number for Dr Diana L Hill is 1356781611 and her current mailing address is Po Box 534, Rison, Arkansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1356781611.

Contact Information

	Dr Diana L Hill, PHARMD
	300 Pine St, Rison, AR 71665-7166
	(870) 325-6262
	Not Available

Healthcare Provider's Profile

Full Name	Dr Diana L Hill
Gender	Female
Speciality	Pharmacist
Location	300 Pine St, Rison, Arkansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1356781611
Provider Enumeration Date: 07/01/2013
Last Update Date: 04/07/2021

Medical Identifiers

Medical identifiers for Dr Diana L Hill such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1356781611	NPI	-	NPPES
PD11947	Other	AR	ARKANSAS STATE BOARD OF PHARMACY

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	PD11947 (Arkansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Diana L Hill is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Diana L Hill, PHARMD Po Box 534, Rison, AR 71665-0534 Ph: (870) 325-6262	Dr Diana L Hill, PHARMD 300 Pine St, Rison, AR 71665-7166 Ph: (870) 325-6262

News Archive

Fabre Kramer Pharmaceuticals receives FDA decision on Gepirone ER for major depressive disorder

Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug application for gepirone extended- release (ER) tablets, submitted for the treatment of adults with major depressive disorder.

Rabies, HIV, cancer and malaria could all be prevented with pills in the future

Rabies, HIV, cancer and malaria could all be prevented with pills in the future, if a new technique using specially modified viruses to deliver vaccines is adopted, according to scientists speaking today (Tuesday, 05 April 2005) at the Society for General Microbiology's 156th Meeting at Heriot-Watt University, Edinburgh.

Innovative technology may prevent hearing loss in military working dogs

Military working dogs played a vital role in the recent raid and death of ISIS leader Abu Bakr al-Baghdadi; however, temporary and permanent hearing loss due to high-decibel noise in training, transport and operations put these animals at risk.

Too much coffee can lead to hallucinations

According to a study by researchers at Durham University people with a higher caffeine intake, from coffee, tea and caffeinated energy drinks, are more likely to experience hallucinatory experiences such as hearing voices and seeing things that are not there.

Dr Diana L Hill, PHARMD - Pharmacist in Rison, AR